Fig. 5: Development of nebulized phage formulation. | Nature Communications

Fig. 5: Development of nebulized phage formulation.

From: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial

Fig. 5: Development of nebulized phage formulation.The alternative text for this image may have been generated using AI.

A Experimental setup of aerosol collection system comprised of a general use mesh nebulizer (right), respiratory low resistance filter (middle), and breathing simulator BRS1100 (left). B Phage relative abundance as measured by quantitative PCR using phage-specific primers and probes, across all stages of a Next Generation Impactor. Source data are provided as a Source Data file.

Back to article page